Foresite Capital Management V, LLC
CIK: 0001792206Latest portfolio: $164.4M · Q4 2025
Holdings
7
Total Value
$164.4M
New Positions
1
Closed Positions
0
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ALMSALUMIS INC. | 5,779,348 | $56.4M | 34.31% | — | |
| 2 | CGONCG Oncology, Inc. | 1,004,050 | $41.7M | 25.36% | — | |
| 3 | IRONDisc Medicine, Inc. | 299,069 | $23.7M | 14.45% | — | |
| 4 | NTRANatera, Inc. | 67,356 | $15.4M | 9.39% | NEW | |
| 5 | LYELLyell Immunopharma, Inc. | 477,078 | $14.7M | 8.93% | — | |
| 6 | HIMSHims & Hers Health, Inc. | 273,151 | $8.9M | 5.39% | — | |
| 7 | MAZEMaze Therapeutics, Inc. | 86,291 | $3.6M | 2.17% | — |
Quarterly Changes
New Positions
- NTRANEW$15.4M
Closed Positions
No closed positions this quarter
Sector Breakdown
Healthcare100.0% ($5.640641688237491e+23T)
Filing History
Fund Information
Foresite Capital Management V, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $164.4M across 7 holdings. The largest position is ALUMIS INC. (ALMS), representing 34.3% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.